Influence of SULT1A1*2 polymorphism on plasma efavirenz concentration in thai HIV-1 patients

Influence of SULT1A1*2 polymorphism on plasma efavirenz concentration in thai HIV-1 patients

Purpose: Plasma efavirenz (EFV) concentrations within therapeutic levels are essential to successfully treat patients suffering from human immunodeficiency virus (HIV) type 1. In addition to the drug-metabolizing enzyme CYP2B6, other phase II drug-metabolizing enzymes and transporters may have an im...

Full description

Saved in:

Bibliographic Details
Main Authors:	Monpat Chamnanphon, Rattanaporn Sukprasong, Andrea Gaedigk, Weerawat Manosuthi, Pajaree Chariyavilaskul, Supeecha Wittayalertpanya, Napatrupron Koomdee, Thawinee Jantararoungtong, Apichaya Puangpetch, Chonlaphat Sukasem
Other Authors:	Ramathibodi Hospital
Format:	Article
Published:	2022
Subjects:	Biochemistry, Genetics and Molecular Biology Pharmacology, Toxicology and Pharmaceutics
Online Access:	https://repository.li.mahidol.ac.th/handle/123456789/76352
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Mahidol University

Similar Items

Effect of ABCB1 3435C>T transporter gene polymorphism on plasma efavirenz concentration in HIV-1 infected Thai adults
by: Sahapat Barusrux, et al.
Published: (2020)

High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections
by: Chonlaphat Sukasem, et al.
Published: (2018)

Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
by: Chonlaphat Sukasem, et al.
Published: (2022)

Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism
by: C. Sukasem, et al.
Published: (2018)

Pharmacogene variation in Thai Plasmodium vivax relapse patients treated with a combination of primaquine and chloroquine
by: Monpat Chamnanphon, et al.
Published: (2020)

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
by: Chalirmporn Atasilp, et al.
Published: (2022)

CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors
by: Chonlaphat Sukasem, et al.
Published: (2018)

Development and Validation of Voriconazole Concentration by LC-MS-MS: Applied in Clinical Implementation
by: Santirat Prommas, et al.
Published: (2018)

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
by: Rattanaporn Sukprasong, et al.
Published: (2022)

CYP2B6 18492T→C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1
by: Weerawat Manosuthi, et al.
Published: (2018)

Cyp2d6 predicts plasma donepezil concentrations in a cohort of thai patients with mild to moderate dementia
by: Monpat Chamnanphon, et al.
Published: (2020)

Polymorphisms of the ApoE (Apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals
by: Tanida Suwalak, et al.
Published: (2018)

HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: Evidence for high risk of drug-induced hypersensitivity
by: Apichaya Puangpetch, et al.
Published: (2018)

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
by: Thawinee Jantararoungtong, et al.
Published: (2022)

CYP2D6 genotype analysis of a Thai population: Platform comparison
by: Monpat Chamnanphon, et al.
Published: (2019)

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults
by: Chonlaphat Sukasem, et al.
Published: (2018)

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults
by: Chonlaphat Sukasem, et al.
Published: (2018)

Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers
by: Chonlaphat Sukasem, et al.
Published: (2018)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
by: Napatrupron Koomdee, et al.
Published: (2022)

HLA-B*58:01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand
by: Chonlaphat Sukasem, et al.
Published: (2018)

Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids
by: Bian, H.S., et al.
Published: (2011)

Genetic polymorphisms of HTR2C, LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs
by: Apichaya Puangpetch, et al.
Published: (2019)

Effects of glucocorticoids on sulfotransferase 1A (SULT1A) activities and the efflux of sulfate conjugates
by: NGO YAN YAN, SHERRY
Published: (2011)

Induction of Human Sulfotransferase1A3 (Sult1A3) by nuclear receptors
by: BIAN HAO SHENG
Published: (2010)

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder
by: Yaowaluck Hongkaew, et al.
Published: (2019)

CYP2D6 polymorphisms and their influence on risperidone treatment
by: Apichaya Puangpetch, et al.
Published: (2018)

Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine
by: Weerawat Manosuthi, et al.
Published: (2018)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
by: Yaowaluck Hongkaew, et al.
Published: (2022)

Apharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HI V-infected Thai patients: A pilot study
by: Pansachee Damronglerd, et al.
Published: (2018)

Successful viral suppression with subsequent efavirenz-based regimen in HIV-1-infected patients who stop nevirapine prior to discontinuation of the NRTI backbone
by: Sukanya Chimsuntorn, et al.
Published: (2018)

Risperidone plasma concentrations are associated with hyperprolactinemia in autism spectrum disorder children: The impact of CYP2D6 polymorphisms
by: Monpat Chamnanphon, et al.
Published: (2022)

CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy
by: Weerawat Manosuthi, et al.
Published: (2018)

Tpmt*3c as a predictor of 6-mercaptopurine-induced myelotoxicity in thai children with acute lymphoblastic leukemia
by: Thawinee Jantararoungtong, et al.
Published: (2022)

Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients
by: Weerawat Manosuthi, et al.
Published: (2018)

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults
by: Sukasem C., et al.
Published: (2014)

Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
by: Chalirmporn Atasilp, et al.
Published: (2020)

Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians
by: Ai Hoc Nguyen, et al.
Published: (2022)

Would a CYP2B6 test help HIV patients being treated with efavirenz?
by: Chonlaphat Sukasem, et al.
Published: (2018)

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
by: Natchaya Vanwong, et al.
Published: (2020)

ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen
by: Weerawat Manosuthi, et al.
Published: (2018)